Overview of Key Findings

Medicare pays for the largest share (> 30%) of naloxone dispensed from retail pharmacies in non-metropolitan areas.Medicare-paid dispensing has grown since 2013, but from 2017-2018 dispensing growth in non-metropolitan areas slowed considerably compared to metropolitan areas (42% v 121%, respectively).As of 2018, the rate of naloxone dispensing to Medicare enrollees in metropolitan areas was approximately double that in non-metropolitan areas (4.9 v 2.9 per 1,000 enrollees, respectively).
Original languageAmerican English
StatePublished - May 1 2021


Dive into the research topics of 'Medicare-Paid Naloxone: Trends in Non-Metropolitan and Metropolitan Areas'. Together they form a unique fingerprint.

Cite this